Partnership

SCM Lifescience and TeraImmune co-develops CAR-Treg for Atopic Dermatitis using a virus-free gene delivery system.

Optipharm and TeraImmune co-develops CAR-Treg which can avoid the immune rejection of transplanted organ from the mini pigs.

Panolos and TeraImmune co-develop bi-specific recombinant fusion proteins that recognize both target cells and Treg cells.